The global vaccines market was valued at USD 90.28 billion in 2023 and is expected to grow from USD 87.57 billion in 2024 to USD 159.28 billion by 2032, reflecting a CAGR of 7.8% during the forecast period. In North America, the vaccines market is projected to expand from USD 37.57 billion in 2023 to USD 38.75 billion in 2024.

The vaccines market is a dynamic and essential component of global health, driven by ongoing efforts to prevent infectious diseases and improve public health outcomes. It encompasses a wide array of vaccine types, including live-attenuated, inactivated, mRNA, viral vector, subunit, and conjugate vaccines, targeting diseases ranging from influenza and HPV to emerging threats like COVID‑19. Advances in vaccine technology, such as rapid development platforms, thermostable formulations, and novel delivery systems, are enhancing efficacy and accessibility. Demand is rising due to increased immunization programs, government initiatives, and global efforts to ensure equitable vaccine distribution. As scientific innovation converges with strengthened supply chains and regulatory support, the vaccines market is poised for robust growth, playing a pivotal role in reducing disease burden and safeguarding populations worldwide.

Continue reading for more details:

**https://www.fortunebusinessinsights.com/industry-reports/vaccines-market-101769**

Market Segmentation

• By Type: Includes inactivated vaccines, live attenuated vaccines, subunit/conjugate vaccines, mRNA vaccines, and toxoid vaccines.
• By Disease Indication: Covers influenza, HPV, COVID-19, hepatitis, pneumococcal, meningococcal, DTP, and others.
• By Age Group: Segments include pediatric, adolescent, adult, and geriatric populations, all contributing to the vaccines market.
• By Route of Administration: Intramuscular, subcutaneous, oral, and intradermal routes play critical roles in the vaccines market.
• By End User: Includes hospitals, clinics, vaccination centers, and public health agencies driving demand in the vaccines market.

List Of Key Companies Profiled in Vaccines Market:

• GlaxoSmithKline plc. (U.K.)
• Sanofi (France)
• Pfizer Inc. (U.S.)
• Merck & Co., Inc. (U.S.)
• Novartis AG (Switzerland)
• Emergent BioSolutions, Inc. (U.S.)
• CSL Limited (Australia)
• Inovio Pharmaceuticals, Inc. (U.S.)